Sol-Gel Technologies (SLGL) Revenue Growth (1y) (2019 - 2026)
Sol-Gel Technologies (SLGL) Revenue Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 35.46% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 64.03% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Sol-Gel Technologies | 226.64 Mn | 216.50 Mn | - | -89.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -89.52% |
| Dec 31, 2025 | 150.36% |
| Sep 30, 2025 | -92.54% |
| Jun 30, 2025 | 217.71% |
| Dec 31, 2024 | -37.81% |
| Sep 30, 2024 | 2,416.90% |
| Jun 30, 2024 | 814.65% |
| Dec 31, 2023 | 347.00% |
| Sep 30, 2023 | -18.39% |
| Jun 30, 2023 | -83.12% |
| Dec 31, 2022 | -99.52% |
| Sep 30, 2022 | -80.46% |
| Jun 30, 2022 | 279.09% |
| Mar 31, 2022 | 427,860.06% |
| Dec 31, 2021 | 911.52% |
| Sep 30, 2021 | -36.86% |
| Jun 30, 2021 | -18.09% |
| Mar 31, 2021 | -79.77% |
| Dec 31, 2020 | -48.83% |
| Sep 30, 2020 | -55.29% |